[go: up one dir, main page]

NO20076349L - Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse - Google Patents

Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse

Info

Publication number
NO20076349L
NO20076349L NO20076349A NO20076349A NO20076349L NO 20076349 L NO20076349 L NO 20076349L NO 20076349 A NO20076349 A NO 20076349A NO 20076349 A NO20076349 A NO 20076349A NO 20076349 L NO20076349 L NO 20076349L
Authority
NO
Norway
Prior art keywords
syn
amino
acbc
analogs
carboxylic acid
Prior art date
Application number
NO20076349A
Other languages
English (en)
Norwegian (no)
Inventor
Mark M Goodman
Weiping Yu
Original Assignee
Univ Emory
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Emory filed Critical Univ Emory
Publication of NO20076349L publication Critical patent/NO20076349L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C07C227/20Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters by hydrolysis of N-acylated amino-acids or derivatives thereof, e.g. hydrolysis of carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00Carboxylic acid amides
    • C07C233/64Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
    • C07C233/81Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups
    • C07C233/82Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/84Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by carboxyl groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom of a saturated carbon skeleton containing rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/24Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atom of at least one of the carbamate groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/26Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids
    • C07C303/28Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of esters of sulfonic acids by reaction of hydroxy compounds with sulfonic acids or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/04Saturated compounds having a carboxyl group bound to a three or four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/04Systems containing only non-condensed rings with a four-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20076349A 2005-06-23 2007-12-11 Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse NO20076349L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69338505P 2005-06-23 2005-06-23
PCT/US2006/023740 WO2007001958A2 (fr) 2005-06-23 2006-06-19 Synthèse stéréo-sélective d'analogues d'acides aminés pour l'imagerie des tumeurs

Publications (1)

Publication Number Publication Date
NO20076349L true NO20076349L (no) 2008-02-15

Family

ID=37595707

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076349A NO20076349L (no) 2005-06-23 2007-12-11 Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse

Country Status (8)

Country Link
US (1) US20060292073A1 (fr)
EP (1) EP1893246A4 (fr)
JP (1) JP5349960B2 (fr)
AU (1) AU2006262425C1 (fr)
CA (1) CA2612187C (fr)
NO (1) NO20076349L (fr)
RU (1) RU2376282C2 (fr)
WO (1) WO2007001958A2 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009505947A (ja) * 2005-06-23 2009-02-12 エモリー・ユニバーシティ 画像化剤
CA2629227C (fr) 2005-11-29 2014-02-25 Nihon Medi-Physics Co., Ltd. Compose precurseur de compose organique marque a l'halogene radioactif
JPWO2008056481A1 (ja) * 2006-11-09 2010-02-25 日本メジフィジックス株式会社 放射性画像診断剤
EP2106808B1 (fr) * 2006-12-21 2018-02-21 Nihon Medi-Physics Co., Ltd. Agent d'imagerie de diagnostic radioactif comprenant de l'acid 1-amino-3-[18f]fluorocyclobutane carboxylique
JP5518337B2 (ja) * 2006-12-27 2014-06-11 日本メジフィジックス株式会社 放射性ハロゲン標識有機化合物の前駆体化合物の製造方法
KR101485445B1 (ko) 2007-02-13 2015-01-22 니혼 메디피직스 가부시키가이샤 방사성 화상진단제의 제조 방법
US7910583B2 (en) 2007-05-04 2011-03-22 Bristol-Myers Squibb Company [6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
JP2010526146A (ja) 2007-05-04 2010-07-29 ブリストル−マイヤーズ スクイブ カンパニー [6,5]−二環式gpr119gタンパク質結合受容体アゴニスト
US7928230B2 (en) * 2007-07-17 2011-04-19 Bristol-Myers Squibb Company Method for modulating GPR119 G protein-coupled receptor and selected compounds
US8258313B2 (en) * 2007-07-19 2012-09-04 Tokuyama Corporation Compound having hydantoin ring and method of producing the same
SI2230229T1 (sl) * 2007-12-19 2017-03-31 Nihon Medi-Physics,Ltd. Postopek za proizvodnjo z radioaktivnim fluorom markirane organske spojine
US8246752B2 (en) 2008-01-25 2012-08-21 Clear Catheter Systems, Inc. Methods and devices to clear obstructions from medical tubes
EP2271372A4 (fr) * 2008-04-14 2012-12-19 Univ Emory Agent d'imagerie
TW201006821A (en) 2008-07-16 2010-02-16 Bristol Myers Squibb Co Pyridone and pyridazone analogues as GPR119 modulators
JP2012532834A (ja) 2009-07-11 2012-12-20 バイエル ファーマ アクチエンゲゼルシャフト シクロアルキル基を用いる放射性標識方法
JPWO2011040574A1 (ja) * 2009-09-30 2013-02-28 国立大学法人京都大学 アゼチジニルメトキシピリジン誘導体の製造方法及びその使用
JP2013523822A (ja) 2010-04-08 2013-06-17 ブリストル−マイヤーズ スクイブ カンパニー Gpr119修飾因子としてのピリミジニルピペリジニルオキシピリジノ類似体
EP2392568A1 (fr) 2010-06-04 2011-12-07 Bayer Pharma Aktiengesellschaft Acides aminés hétérocycliques pour imagerie du cancer de la prostate
GB201021530D0 (en) * 2010-12-20 2011-02-02 Ge Healthcare Ltd Purification of precursor compound by crystallisation
BR112013021021A2 (pt) * 2011-02-17 2016-08-02 Bayer Ip Gmbh 3- (bifenil - 3 - il) - 8, 8 - difluoro - 4 - hidroxi - 1 - azaspiro [4, 5] dec - 3 - eno - 2 - onas substituídas para terapia e cetoenóis espirocíclicos substituídos com halogéneo
MX339188B (es) * 2011-03-11 2016-05-13 Bayer Ip Gmbh Derivados de 1h-pirrolidina -2,4-diona espirociclicos cis-alcoxi-sustituidos.
EP2734494B1 (fr) * 2011-07-21 2019-01-02 GE Healthcare Limited Composés précurseurs et leurs procédés de fabrication
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) * 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process
CN105431428A (zh) 2013-06-03 2016-03-23 拜耳制药股份公司 取代的苯并噁唑
UY35592A (es) 2013-06-03 2014-12-31 Bayer Pharma AG Benzoxazoles sustituidos
TWI868065B (zh) * 2018-04-10 2025-01-01 德商拜耳廠股份有限公司 用於製備經取代之環己烷胺基酸酯和經螺縮酮取代之環狀酮烯醇之方法
WO2021225147A1 (fr) * 2020-05-07 2021-11-11 国立大学法人東京工業大学 Méthode de concentration d'astate simple
CN111574389B (zh) * 2020-05-14 2023-08-18 河北威远生物化工有限公司 1-氨基-4-取代环己基羧酸及其盐的顺式异构体的制备方法
CN114031652B (zh) * 2021-11-04 2023-05-26 北京师范大学 一种含环己烷的葡萄糖衍生物及其应用
CN118955332A (zh) * 2024-07-31 2024-11-15 德阳悦合生物医药科技有限公司 一种作为医药中间体的化合物叔丁基甲基(3-酮环丁基)氨基甲酸酯的制备方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855208A (en) * 1971-05-24 1974-12-17 Becton Dickinson Co Derivatives of digoxigenin
US4695588A (en) * 1977-06-01 1987-09-22 Merck & Co., Inc. Fluorinated amino acids
US4325961A (en) * 1977-06-01 1982-04-20 Merck & Co., Inc. Fluorinated amino acids
US4743691A (en) * 1977-07-11 1988-05-10 Merrell Dow France Et Cie 2-halomethyl derivatives of 2-amino acids
US4483870A (en) * 1978-07-24 1984-11-20 Merck & Co., Inc. α-Difluoromethyl amino acids and hypertension treating compositions thereof
US4358434A (en) * 1979-12-19 1982-11-09 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4390517A (en) * 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US4942231A (en) * 1984-05-24 1990-07-17 Mallinckrodt, Inc. Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound
US4760091A (en) * 1985-10-01 1988-07-26 The Dow Chemical Company Method of controlling phytopathogenic fungus
US5227467A (en) * 1987-08-03 1993-07-13 Merck & Co., Inc. Immunosuppressive fluorinated cyclosporin analogs
US5116599A (en) * 1989-07-31 1992-05-26 Johns Hopkins Univ. Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri
ZA907743B (en) * 1989-10-03 1991-07-31 Merrell Dow Pharma Radiolabeled anticoagulant peptides
US5128118A (en) * 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
US6096874A (en) * 1990-10-01 2000-08-01 Board Of Regents, The University Of Texas System High affinity tamoxifen derivatives
US5698179A (en) * 1992-02-25 1997-12-16 Neuro Imaging Technologies, Llc Iodinated neuroprobe for mapping monoamine reuptake sites
US5310912A (en) * 1992-02-25 1994-05-10 Research Biochemicals Limited Partnership Iodinated neuroprobe for mapping monoamine reuptake sites
US5637759A (en) * 1992-07-30 1997-06-10 The Regents Of The University Of California Metal-ligating amino acid derivatives for MRI and for peptide synthesis
US5493026A (en) * 1993-10-25 1996-02-20 Organix, Inc. Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders
US6043271A (en) * 1994-08-03 2000-03-28 Sarawak Medichem Pharmaceuticals, Inc. Method for the preparation of (±)-calanolide A and intermediates thereof
IL117574A0 (en) * 1995-04-03 1996-07-23 Bristol Myers Squibb Co Processes for the preparation of cyclobutanone derivatives
US5808146A (en) * 1995-11-09 1998-09-15 Emory University Amino acid analogs for tumor imaging
AUPO763197A0 (en) * 1997-06-30 1997-07-24 Sigma Pharmaceuticals Pty Ltd Health supplement
RU2123701C1 (ru) * 1998-05-26 1998-12-20 Общество с ограниченной ответственностью "Импакт" Набор для ферментного анализа и способ его получения
AU4974700A (en) * 1999-04-22 2000-11-10 Emory University Fluoroalkenyl nortropanes
US6399042B1 (en) * 1999-04-26 2002-06-04 Emory University 4-fluoroalkyl-3-halophenyl nortropanes
US6843979B2 (en) * 1999-04-26 2005-01-18 Emory University 4-haloethenylphenyl tropane:serotonin transporter imaging agents
US7146209B2 (en) * 2000-05-08 2006-12-05 Brainsgate, Ltd. Stimulation for treating eye pathologies
GB0121439D0 (en) * 2001-09-05 2001-10-24 Univ St Andrews An enzymatic process for the generation of organo-fluorine compounds
GB0206117D0 (en) * 2002-03-15 2002-04-24 Imaging Res Solutions Ltd Use of microfabricated devices
CN101041674A (zh) * 2002-04-30 2007-09-26 埃默里大学 肿瘤成像化合物
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
US20050197350A1 (en) * 2003-03-31 2005-09-08 Taisho Pharmaceutical Co., Ltd. Novel quinoline, tetrahydroquinazoline, and pyrimidine derivatives and methods of treatment related to the use thereof
BRPI0413880A (pt) * 2003-08-27 2006-10-24 Boehringer Ingelheim Int compostos cicloalquilaminoácidos, processo para a obtenção dos mesmos
AU2006250594B2 (en) * 2005-05-23 2011-06-16 Nihon Medi-Physics Co., Ltd. Novel organic compound and method for producing radioactive halogen-labeled organic compound using the same
JP2009505947A (ja) * 2005-06-23 2009-02-12 エモリー・ユニバーシティ 画像化剤

Also Published As

Publication number Publication date
RU2376282C2 (ru) 2009-12-20
EP1893246A2 (fr) 2008-03-05
RU2008100844A (ru) 2009-07-27
CA2612187C (fr) 2013-05-07
CA2612187A1 (fr) 2007-01-04
WO2007001958A3 (fr) 2007-05-31
JP2008546783A (ja) 2008-12-25
WO2007001958A2 (fr) 2007-01-04
US20060292073A1 (en) 2006-12-28
EP1893246A4 (fr) 2009-05-06
AU2006262425B2 (en) 2011-12-08
AU2006262425A1 (en) 2007-01-04
JP5349960B2 (ja) 2013-11-20
AU2006262425C1 (en) 2012-06-21

Similar Documents

Publication Publication Date Title
NO20076349L (no) Stereoselektiv syntese av aminosyreanaloger for tumorbilleddannelse
MX2010005122A (es) Estabilizacion de radiofarmaceuticos.
BG108497A (en) Solid-phase nucleophilic fluorination
ES2304944T3 (es) Composicion que comprende mx-dtpa y su utilizacion para producir un mx-dtpa radiomarcado.
Ogawa et al. Development of novel radiogallium-labeled bone imaging agents using oligo-aspartic acid peptides as carriers
WO2006067376A3 (fr) Procedes de radiomarquage
US20210040126A1 (en) 68Ga-LABELED NOTA-CHELATED PSMA-TARGETED IMAGING AND THERAPEUTIC AGENTS
JP2006528644A5 (fr)
NO20091379L (no) Effektiv syntese av chelatorer for nukleaer bildebehandling og radioterapi: blandinger og anvendelser
Thompson et al. A two-step fluorinase enzyme mediated 18 F labelling of an RGD peptide for positron emission tomography
CZ20032597A3 (cs) Analogy kyseliny askorbové pro metaloradiofarmaceutika
WO2007148089A3 (fr) Méthodes de radiomarquage
ATE355259T1 (de) Radiofluorierungsverfahren
MX2011010295A (es) Reactivos de radiomarcado y metodos.
AR071054A1 (es) Compuestos para usar en la formacion de imagenes el diagnostico y/o el tratamiento de enfermedades del sistema nervioso central o de tumores, metodos de preparacion, composiciones farmaceuticas, usos y metodos de deteccion de monoamina oxidasa.
Ruan et al. Novel 99m Tc labelled complexes with 2-nitroimidazole isocyanide: Design, synthesis and evaluation as potential tumor hypoxia imaging agents
AU2014225381B2 (en) Vinylsulfone-based 18f-labeling compositions and methods and uses thereof
NO20074576L (no) Radiolabeled Gallium Complexes, Methods for Synthesis and Use For Pet Imaging of EGFR Expression in Malignant Tumors
CA2476996A1 (fr) Procedes de prevention ou de traitement de l'arythmie cardiaque
TW200738271A (en) Methods of making radiolabeled tracers and precursors thereof
BRPI0409101A (pt) método para produzir um complexo de gálio radiomarcado
Rana et al. Optimization of a novel peptide ligand targeting human carbonic anhydrase IX
US8722014B2 (en) 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof
WO2009025914A3 (fr) Analogues de fluorobenzamide radiomarques, synthese et utilisation de ces analogues dans l'imagerie diagnostique
KR20110009166A (ko) 신규한 [f-18]-표지된 l-글루탐산 및 l-글루타민 유도체 (ⅱ), 그의 용도 및 그의 제조 방법

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application